Drug Information

Drug General Information
Drug ID
D0H0KA
Former ID
DNC002354
Drug Name
Macbecin
Drug Type
Small molecular drug
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Investigative [536886]
Therapeutic Class
Anticancer Agents
Structure
Download
2D MOL

3D MOL
Formula
C30H42N2O8
Canonical SMILES
CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)N=C2CC(=O)C=C(C1OC)C2=O)C<br />)C)OC(=O)N)C)C)OC)OC
InChI
1S/C30H42N2O8/c1-16-10-9-11-17(2)29(35)32-23-15-21(33)14-22(25(23)34)27(38-7)20(5)13-24(37-6)28(39-8)19(4)12-18(3)26(16)40-30(31)36/h9-12,14,16,19-20,24,26-28H,13,15H2,1-8H3,(H2,31,36)/b10-9-,17-11+,18-12+,32-23?/t16-,19-,20-,24-,26+,27+,28+/m0/s1
InChIKey
RDRSBLOJWULGIA-JRLGARQZSA-N
PubChem Compound ID
46943437
PubChem Substance ID
99455804
Target and Pathway
Target(s) Heat shock protein HSP90 Target Info Inhibitor [536886]
References
Ref 536886Recent advances in Hsp90 inhibitors as antitumor agents. Anticancer Agents Med Chem. 2008 Oct;8(7):761-82.
Ref 536886Recent advances in Hsp90 inhibitors as antitumor agents. Anticancer Agents Med Chem. 2008 Oct;8(7):761-82.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.